Prevalence and characteristics of extended-spectrum beta-lactamase- producing Klebsiella pneumoniae isolated from pediatric inpatients with respiratory tract infections at a teaching hospital in China

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 3, 2014, Pages 200-203

  Li, Binxian ^a   Li, Mingcheng ^a   Qu, Li ^a   Wang, Miao ^a   Guo, Jie ^b  

^a BEIHUA UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

ESBL producing Klebsiella pneumoniae; Genotype; Pediatric setting

Indexed keywords

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CHINA; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PREVALENCE; RESPIRATORY TRACT INFECTIONS;

EID: 84894334105     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.859393     Document Type: Article

References (15)

1. Li M, Wang L, Li S. Survey on bacterial resistance and antibiotics usage among paediatrics. (Abstract in English). Chinese Journal of Public Health 2007;23:650-1.
2. Yu JL, Wu SX, Jia HQ. Study on antimicrobial susceptibility of bacteria causing neonatal infections: a 12 year study (1987-1998). Singapore Med J 2001;42:107-10.
3. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors . Clin Microbiol Rev 1998;11:589-603.
4. Thaver D, Ali SA, Zaidi AK. Antimicrobial resistance among neonatal pathogens in developing countries. Pediatr Infect Dis J 2009;28:S19-21.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI/ NCCLS M100-S19. Wayne, PA: CLSI; 2009.
6. Tullus K, Berglund B, Fryklund B, Kuhn I, Burman LG. Epidemiology of fecal strains of the family Enterobacte-riaceae in 22 neonatal wards and influence of antibiotic policy. J Clin Microbiol 1998;26:1166-70.
7. Mendes C, Kiffer C, Segura A, Ribeiro J, Turner P. Klebsiella pneumoniae with multiple antimicrobial resistance. Braz J Infect Dis 2004;8:109-11.
8. Chen YH, Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria . J Infect 2011;62:280-91.
9. Corkill JE, Cuevas LE, Gurgel RQ, Greensill J, Hart CA. SHV-27, a novel cefotaxime-hydrolysing P-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital. J Antimicrob Chemother 2001;47:463-5.
10. Hoban DJ, Bouchillon SK, Hawser SP, Badal RE, Labombardi VJ, DiPersio J. Susceptibility of Gram-negative pathogens isolated from patients with complicated intraabdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010; 54:3031-4.
11. Yan JJ, Wu SM, Tsai SH, Wu JJ, Su IJ. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum P-lactamase and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrob Agents Chemother 2000;44:1438-42.
12. Hansen DS, Schumacher H, Hansen F, Stegger M, Hertz FB, Schenning K, et al. Extended-spectrum P-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, P-lactamase distribution, phylo-groups, and co-resistance. Scand J Infect Dis 2012;44: 174-81.
13. Quale JM, Landman D, Bradford PA, Visalli M, Ravishankar J, Flores C, et al. Molecular epidemiology of a citywide outbreak of extended spectrum P-lactamase producing Klebsiella pneumoniae infection. Clin Infect Dis 2002;35:834-41.
14. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum P-lactamase. J Hosp Infect 2001;47: 53-9.
15. Bradford PA. Extended-spectrum P-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14: 933-51.